Experiment summary for ENCSR474KBG
doi:10.17989/ENCSR474KBG
Summary
- Status
- released
- Assay
- ChIP-seq (TF ChIP-seq)
- Target
- CSDC2
- Biosample summary
- Homo sapiens SK-N-SH genetically modified (insertion) using CRISPR targeting H. sapiens CSDC2 treated with 6 μM all-trans-retinoic acid for 48 hours
- Biosample Type
- cell line
- Replication type
- isogenic
- Description
- eGFP-CSDC2 ChIP-seq on human SK-N-SH
- Treatments
- 6 μM all-trans-retinoic acid (CHEBI:15367) for 48 hours
- Nucleic acid type
- DNA
- Size range
- 250-450
- Fragmentation methods
- sonication (Bioruptor Pico)
- Platform
- Illumina HiSeq 4000
- Controls
Attribution
ENCODE4 project
- Lab
- Michael Snyder, Stanford
- Award
- UM1HG009442 (Michael Snyder, Stanford)
- Project
- ENCODE
- External resources
- Aliases
- michael-snyder:pCS-15, michael-snyder:pCS-eGFP-CSDC2 SK-N-SH ChIP
- Date submitted
- December 22, 2018
- Date released
- June 30, 2020
- Annotation (gkmsvm-model)
Isogenic replicates
Isogenic replicate | Technical replicate | Summary | Biosample | Modifications | Antibody | Library |
---|---|---|---|---|---|---|
2 | 1 | Homo sapiens SK-N-SH cell line genetically modified (insertion) using CRISPR targeting H. sapiens CSDC2 treated with 6 μM all-trans-retinoic acid for 48 hours | ENCBS948IUU | ENCGM678TAK | ENCAB728YTO | ENCLB663ZCN |
1 | 1 | Homo sapiens SK-N-SH cell line genetically modified (insertion) using CRISPR targeting H. sapiens CSDC2 treated with 6 μM all-trans-retinoic acid for 48 hours | ENCBS377IYO | ENCGM678TAK | ENCAB728YTO | ENCLB340GTD |